ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Molecular phenotypic linkage between N6-methyladenosine methylation and tumor immune microenvironment in hepatocellular carcinoma

Zhang, Feng; Bi, Junming; Liao, Jiasheng; Zhong, Wenhui; Yu, Min; Lu, Xin; Che, Jinhui; Chen, Zhiyuan; Xu, Haobin; Hu, Shixiong*; Liu, Yubin*; Guo, Shuijiao*广东省人民医院; 南方医科大学; 汕头大学; 中国医学科学院; 中国医学科学院北京协和医院
Journal of Cancer Research and Clinical Oncology2023-2-24DOI: 10.1007/s00432-023-04589-2
11阅读
引用收藏
分享

摘要

PurposeThe crucial role of N-6-methyladenosine (m(6)A) methylation in anti-tumor immunity and immunotherapy has been broadly depicted. However, the molecular phenotypic linkages between m(6)A modification pattern and immunological ecosystem are expected to be disentangled in hepatocellular carcinoma (HCC), for immunotherapeutic unresponsiveness circumvention and combination with promising drug agents.MethodsModification patterns of m(6)A methylation were qualitatively dissected according to the large-scale HCC samples profiling. We then determined the immune phenotypic linkages by systematically evaluating their tumor microenvironment composition, immune/stromal-relevant signature, immune checkpoints correlation, and prognostic value. Individual quantification of m(6)A methylation pattern was achieved by m(6)Ascore construction, intensified by longitudinal single-cell analysis of immunotherapy cohort and validated by the transcriptomic profiles of our in-hospital GDPH-HCC cohort. Candidate therapeutic agents were also screened out.ResultsThree distinct m(6)A methylation patterns were determined in high accordance with inflamed-, excluded-, and desert-immunophenotype. To be precise, Immune-inflamed high-m(6)Ascore group was characterized by activated immunity with favorable prognosis. Stromal activation and absence of immune cell infiltration were observed in low-m(6)Ascore phenotype, linked to impaired outcome. Patients with low-m(6)Ascore demonstrated diminished responses and clinical benefits for cohorts receiving immunotherapy. The above credible linkage between m(6)A methylation pattern and tumor immune microenvironment was robustly validated in our GDPH-HCC cohort. Single-cell dynamic change of m(6)A methylation level in exhausted CD8 T cell and fibroblast was depicted in immunotherapy cohort fore and art. Derived from m(6)A methylation pattern, seven potential frontline drug agents were recognized as promising choice for high-m(6)Ascore patients.ConclusionOur work bridged the credible linkage between epigenetics and anti-tumor immunity in HCC, unraveling m(6)A modification pattern as immunological indicator and predictor for immunotherapy. Individualized m(6)Ascore facilitated strategic choices to maximize therapy-responsive possibility.

学科与关键词

关键词
m(6)A methylationImmune microenvironmentEpigenetic modificationHepatocellular carcinomaImmunotherapy
相关
加载中…
  • N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma
    Wang, Gaofeng; Zeng, Dongqiang; Sweren, Evan; Miao, Yong; Chen, Ruosi; Chen, Junjun; Wang, Jin; Liao, Wangjun; Hu, Zhiqi; Kang, Sewon; Garza, Luis A.*Journal of Investigative Dermatology, 2023, 143(8).被引 1
  • H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma
    Yu, Linyuan; Ji, Tao; Liao, Wei; Xu, Yuyan; Fang, Yinghao; Zhu, Qing; Nie, Jianmin; Yang, Dinghua*Clinical Epigenetics, 2023, 15(1): 43.被引 2
  • Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response
    Jiang, Hongye; Ning, Gang; Wang, Yensheng; Lv, Weibiao*DISEASE MARKERS, 2021, 2021: 5576683.被引 23
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Cancer Research and Clinical Oncology
发表日期
2023-02-24
DOI
10.1007/s00432-023-04589-2
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81972792]; Natural Science Foundation of Guangdong Province, People's Republic of China [2019A15155011733, 2021A1515010952]

作者

  • Z

    Zhang, Feng (第一作者)

    guangdong prov peoples hosp · southern med univ · shantou univ

  • B

    Bi, Junming

    guangdong prov peoples hosp · southern med univ

查看全部 12 位作者收起作者
  • L

    Liao, Jiasheng

  • Z

    Zhong, Wenhui

    chinese acad med sci · peking union med coll

  • Y

    Yu, Min

    guangdong prov peoples hosp · southern med univ

  • L

    Lu, Xin

    guangdong prov peoples hosp · southern med univ

  • C

    Che, Jinhui

    guangdong prov peoples hosp · southern med univ

  • C

    Chen, Zhiyuan

    guangdong prov peoples hosp · southern med univ

  • X

    Xu, Haobin

    guangdong prov peoples hosp · southern med univ

  • H

    Hu, Shixiong (通讯)

    guangdong prov peoples hosp · southern med univ

  • L

    Liu, Yubin (通讯)

    guangdong prov peoples hosp · southern med univ

  • G

    Guo, Shuijiao (通讯)

    guangdong prov peoples hosp · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417